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A BST R AC T   
 
Aim: To determine the epidemiological and antibiotic susceptibility profile of bacterial uropathogens 
in outpatients. 
Methods: This study analyzed data taken from outpatients with urinary tract infection (UTI) collected 
from January 2013 to January 2018 in the laboratory of Maltepe Medical Center in İstanbul. Species 
of uropathogens were made using routine laboratory methods. Antibiotic resistance profile of 
uropathogens was determined using disk diffusion method.  
Results: There were 7741 urine cultures and 1563 of them were positive for bacterial uropathogens. 
The identified major organisms were Gram-negative bacteria (1376/1563; 88.0%), while Gram-
positive bacteria only 5.4% (187/1563) were representing. The patients with positive samples, 84.8% 
(1326/1563) were female and 15.1% (237/1563) were male. The main isolated uropathogen was E. 
coli (58.1%), followed by Enterobacter spp (10.1%), P. mirabilis (8.6%), K. pneumoniae (7.8%), 
Enterococcus (4.7%) and P. aeruginosa (3.1%). E. coli was more prevalent in all age groups. A total 
of 74.8% of E. coli isolates were resistant to ampicillin and the lowest resistance rate was to imipenem 
(0.3%). Enterobacter species were found to have higher resistance to ampicillin (87.3%), lower 
resistance to carbapenem (1.8%) and amikacin (6.9%). 
Conclusion: Due to the emergence of various antibiotics resistant bacterias, it was concluded that 
empirical antibiotic treatment should be reviewed periodically according to the regions. Empirical 
therapy must be based on local epidemiological data, which should be constantly updated. Therefore, 
the results of our study may help physicians to select an appropriate antimicrobial therapy. 
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Introduction 
Urinary tract infections are a serious public 
health problem with urinary symptoms 
accompanied by bacteriuria. It is one of the 
most common bacterial infections seen with a 
high rate of financial cost and morbidity [1,2]. 
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The agents that cause urinary tract infection 
vary by region and besides that, antibiotic 
susceptibility and resistance profiles also vary 
[2]. Antibiotic resistance rates of uropathogenic 
bacteria are increasing day by day worldwide. 
[1,2,3]. The treatment of the cases is usually 
done empirically considering the antibiotic 
susceptibility and resistance profiles of 
uropathogens. These treatments can result in 
long-term alteration of the normal microbiota 
and development of resistant microorganisms 
[3-5].  The most common bacterial 
uropathogens of UTI are Escherichia coli, 
Klebsiella pneumoniae, Proteus mirabilis, 
Enterococcus faecalis and Staphylococcus 
saprophyticus [2-4]. Today in the treatment of 
urinary tract infections most commonly used 
chemotherapeutics are amoxicillin, 
cotrimoxazole, aminoglycosides, 
cephalosporins, nitrofurantoin, and quinolone 
group antibiotics. As a result of widespread and 
misuse, there is increasing resistance to these 
antibiotics [1].  
In order to enhance patient health outcomes and 
reduce the emergence of resistance to 
antibiotics, coordinated strategies are needed. It 
is essential to carry out surveillance of the 
bacterial spectrum. Resistance to antibiotics of 
locally occurring uropathogens that could serve 
as a basis for empirical treatment of UTIs and 
surgical prophylaxis [6,7].  
Antibiotic resistance rates can vary 
geographically and include significant 
differences between countries and regions. 
Accurate bacteriological recordings of culture 
results provide guidance to empirical treatment 
before sensitivity patterns are found. Because 
many of the urinary tract infections are 
empirically treated, the choice of antibiotics 
should be determined according to the most 
likely pathogen and expected resistance profile 
in a geographic area [1,7,8].  
The purpose of this retrospective study was to 
determine the isolation frequency and 
antimicrobial resistance patterns of 
uropathogens through 5 years of results in 
outpatients in a single center in Turkey.  
 
Methods 
The study was ethically approved by the local 
ethical committee of İstanbul Memorial 
Hospital (Protocol number: 2018/7-4). This 
retrospective study involved all urine samples 
analyzed during the period from January 2013 
to January 2018 in the medical microbiology 
laboratory of Maltepe Medical Center in 
İstanbul. Patients received any antimicrobial 
treatment before sampling were excluded. All 
of the outpatients, all of the age and gender, all 
departments of the Medical Center were 
included.  
Urine samples were collected from outpatients. 
Urine culture results were analyzed using the 
‘’Laboratory Information System’’ database. 
Identification codes were used for data and 
results were used solely for scientific purposes. 
Age, gender, growing bacterial species and 
antibiotic resistance rates were recorded in the 
excel file. Age groups; between 0-17 pediatric 
age, 18-64 adult age, and 65 years old and older 
were accepted as geriatrics age groups.  All of 
the data were entered by Microsoft Excel 2007. 
 
Sample Collection 
While medium flow urine is taken in 
outpatients, urinary aspiration method was used 
in patients with urinary catheters. Pediatric 
urine samples were collected by special plastic 
bags produced differently for girls and boys. 
After routine cleaning procedures in male and 
female patients, medium flow urine was 
collected. The patients were guided to pass 
urine sample of at least 20 mL by un-touched, 
sterile technique in a wide-mouth screw- 
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capped sterile container. Samples were 
analyzed in the laboratory within 1 hour after 
collection.  
 
Isolation and identification of uropathogens  
All samples were inoculated on blood agar 
EMB agar (Bioanalyse /Turkey) and incubated 
at 35±2℃ for 24 h. Following incubation, the 
bacterial colonies were counted and counts of 
≥105colony-forming units (CFUs)/mL were 
included in the study. Isolated uropathogens 
were identified to species level using routine 
laboratory methods. 
 
Antibiotic susceptibility test 
Antibiotic susceptibility patterns of the 
bacterial isolates were determined using the 
Kirby-Bauer disc diffusion method on Mueller-
Hinton (MHA) agar (Ekbak/Turkey). The 
antibiotic disc (Bioanalysis/Turkey) containing 
the following antibiotics: Ampicillin 10 𝜇g, 
ampicillin/sulbactam 30 𝜇g, cefuroxime 30 𝜇g, 
cefprozil 30 𝜇g, cefixime 30 𝜇g, ceftrıaxone 
30𝜇g, imipenem 10𝜇g, ciprofloxacin10𝜇g, 
Levofloxacın 5 𝜇g, gentamicin  30 𝜇g, amikacin 
30 𝜇g, trimethoprim/sulfamethoxazole (TMX) 
25 𝜇g and nitrofurantoin 200 𝜇g.  
Standardized overnight culture of each isolate 
was used MHA. The antibiotic disks were 
aseptically placed on the surface of the culture 
media.  After incubated, the inhibition zones 
were measured and isolates were classified as 
susceptible, intermediate and resistant 
according to the National Committee for 
Clinical Laboratory Standards [8]. 
 
Statistical analysis 
Data from the study was entered in Microsoft 
Excel 2007 and analyzed in SPSS 13.0 was 
used to analyze general data (SPSS, Chicago, 
IL, USA). Chi-square test was used to compare 
the relationship between age and sex with 
uropathogens and antibiotic susceptibility ratio. 
For statistical evaluations, frequency, 
percentage and mean ± standard deviations 
were calculated and the study variables 
presented in the form of tables. 
 
Results  
Characteristics of the patients 
A total of 7741 urine samples were analyzed 
during the five years period, among which 1563 
samples (20.1%) were positive, whereas 6178 
(79.8%) sample were negative for UTI. All of 
the total urine samples came from the outpatient 
department. Patients with positive samples 
1326 (84.8%) were female and 237 (15.1%) 
were male. The age of our patients ranged from 
0 to 96 years, with a mean of 31.9 ± 28.9 years 
and a median of 27 years. 
 
Microbiological profile 
When uropathogens were evaluated according 
to culture results, Gram-negative isolates were 
more dominant than Gram-positive isolates. 
(Table 1). While 1376 (88.0%) of all isolated 
pathogens were Gram-negative bacteria and 
187 (11.9%) were Gram-positive bacteria. The 
main isolated pathogen was E. coli (58.1%), 
followed by Enterobacter spp (10.1%), P. 
mirabilis (8.6%), K. pneumoniae (7.8%), 
Enterococcus (4.7%), P. aeruginosa (3.1%), 
Group B streptococcus (3.0%), Coagulase-
negative staphylococci (2.2%), Staphylococcus 
aureus, (1.8%). The most common bacteria 
observed in women were Escherichia coli 
(88.6%) Enterobacter species (88.0%), Group 
B streptococcus (88.0%) while the men were 
Pseudomonas aeruginosa (38.0%), Proteus 
mirabilis (30.8%), Coagulase-negative 
staphylococci (25.7%) (Table 2).  
E. coli was more prevalent in all age groups. 
(pediatric 57.7%, adult 58.7% and elderly 
57.4%).  Proteus mirabilis and Enterobacter 
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species were the most common agents isolated 
from pediatric patients, while Enterobacter 
species and K. Pneumoniae were in adult and 
geriatric patients. (Table 3).   
 
Table 1. Distribution of the Gram-negative and 
Gram-positive bacterial isolates from urine 
samples. 
Microorganism N % 
Gram-negative 1376 88.0 
Escherichia coli 909 58.1 
Enterobacter species 159 10.1 
Proteus mirabilis 136 8,6 
Klebsiella pneumoniae 122 7.8 
Pseudomonas aeruginosa 50 3.1 
Gram-positive 187 12.0 
Enterococcus 75 4.7 
Group B streptococcus 48 3.0 
Coagulase-negative 
staphylococci 
35 2.2 
Staphylococcus aureus 29 1.8 
Total 1563 100 
 
 
 
 
 
 
Antibiotic susceptibility  
Among the isolated microorganisms, the 
antibiotic resistance of Gram-negative and 
Gram-positive bacteria groups were analyzed. 
The antibiotic resistance profile of 
uropathogens is shown in the table (Table 4-5). 
A total of 74.8% of E. coli isolates were 
resistant to ampicillin, resistance to 
cephalosporins were ranged from 21.3% to 
35.5% and, 35.4% were resistant to 
trimethoprim-sulfamethoxazole. Resistance to 
fluoroquinolones were lower (18.9% 
ciprofloxacin and 17.7% levofloxacin), as well 
as the resistance to aminoglycosides (25.6% for 
gentamicin, and 6.2% for amikacin). The 
lowest resistance rate was to carbapenem 
(0.3%). Enterobacter species showed higher 
resistance to ampicillin (87.3%), lower 
resistance to carbapenem (1.8%) and amikacin 
(6.9%). Proteus spp. were showed higher 
resistance to amoxicillin (61.7%) nitrofurantoin 
(48.1%) and trimethoprim-sulfamethoxazole 
(43.7%).  
 
 
 
 
 
Uropathogens                          Isolates (N / %) 
Male Female Total P values 
Escherichia coli 103 (11.4) 806 (88.6) 909 (58,1) 0.000 
Enterobacter species 19 (11.9) 140 (88.0) 159 (10.1) 0.000 
Proteus mirabilis 42 (30.8) 94 (69.1) 136 (8,6) 0.000 
Klebsiella pneumoniae 27 (22.1) 95 (77.8) 122 (7.8) 0.000 
Enterococcus 12 (16.0) 63 (84.0) 75 (4.79) 0.000 
Pseudomonas aeruginosa 19 (38.0) 31 (62.0) 50 (3.19) 0.001 
Group B streptococcus 1 (2.0) 47 (88.0) 48 (3.07) 0.000 
Coagulase-negative staphylococci 9 (25.7) 26 (74.2) 35 (2.23) 0.000 
Staphylococcus aureus 5 (17.2) 24 (82.7) 29 (1.8) 0.000 
Total 237 (15.1) 1326 (84.8) 1563 (100) 0.000 
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 Klebsiella pneumoniae showed high degree of 
resistance to ampicillin (97.5%), trimethoprim-
sulfamethoxazole (44.2%) cefprozil (43.4%). 
Pseudomonas aeruginosa was showed lower 
resistance rates to carbapenem, Quinolones and 
Aminoglycosides while it was resistant to all of 
the other groups. Enterococcus spp., the most 
commonly isolated Gram-positive 
uropathogen, showed a low grade of resistance 
to ampıcıllın (13.3%), amoxicillin-clavulanic 
acid (10.6%) and carbapenem (6.6%), but a 
high grade of resistance to all of the other 
groups of antibiotic. The other Gram-positive 
bacterial resistance to antibiotics is summarized 
in the table-4 and table-5. 
 
Discussion 
UTI is one of the most common infectious 
diseases diagnosed in outpatients. It is the most 
common problem throughout the world, 
particularly in developing countries and 
associated with substantial morbidity and 
recurrent infections.  Importantly, the 
epidemiology of UTI varies among countries 
due to geography variation and antibiotic use 
[2].  Unfortunately, antibiotic resistance has 
become an increasingly pressing problem in 
many countries [1-3]. In our study, the positive 
rate    of  urinary   cultures   was   found  to   be 
 
20.1% (1563 out of 1741 samples) and nearly 
85% (1326 (out of 1563 samples) of all isolates 
were obtained from women. Women are more 
likely to experience UTIs than men. It is well 
documented that UTI is more common in 
females than in males due to the anatomical 
differences of urogenital organs between the 
two sexes. Our study finding is in agreement 
with other studies [6,9 -12]. UTI is prevalent in 
the study area and the most frequently isolated 
uropathogens were Gram- negative bacteria. 
Among the isolated pathogens 88.0 % (n=1376) 
were Gram- negative bacteria and 11.9% 
(n=187) were Gram-positive bacteria in our 
study. Gram-negative bacteria were the most 
commonly isolated organisms in the present 
study, and previous studies have reported 
similar findings [1-3].  
In our study, Escherichia coli was the most 
frequently isolated microorganism. Our finding 
was consistent with similar studies conducted 
locally [13–17] and internationally [10-12]. 
The main isolated pathogen was E. coli 
followed by Enterobacter spp, P Mirabilis, K. 
pneumoniae respectively. Our findings are 
different from the literature. Because Klebsiella 
pneumonia was the second most frequent 
bacteria in the national and international 
literature [10-17]. 
Uropathogens Pediatric (N / %) Adult (N / %) Elderly (N / %) Total (N) 
Escherichia coli 378 (41.5) 343 (37.7) 188 (9.2) 909 
Enterobacter species 75 (47.1) 53 (33.3) 31 (19.4) 159 
Proteus mirabilis 93 (68.3) 20 (14.7) 23 (16.9) 136 
Klebsiella pneumoniae 42 (34.4) 53 (43.4) 27 (22.1) 122 
Enterococcus 17 (22.6) 39 (52.0) 19 (25.3) 75 
Pseudomonas aeruginosa 16 (32.0) 8 (16.0) 26 (52.0) 50 
Group B streptococcus 11 (22.9) 33 (68.7) 4 (8.3) 48 
Coagulase-negative staphylococci 12 (34.2) 19 (54.2) 4 (11.4) 35 
Staphylococcus aureus 8 (27.5) 16 (55.1) 5 (17.2) 29 
Total        654(41.8) 584(37.3) 327(20.9) 1563 
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Species (Na)  
Quinolones Aminoglycosides                                 Others 
Ciprofloxacin  
N   (%R) 
Levofloxacin  
N   (%R) 
Gentamicin 
N   (%R) 
Amikacin  
N (%R) 
TMX  
N   (%R) 
Nitrofurantoin  
N  (%R) 
Escherichia coli   (909) 181 (19.9) 161 (17.7) 233 (25.6) 57 (6.2) 322 (35.4) 82 (9.0) 
Enterobacter species  (159) 46 (28.9) 35 (22.0) 46 (28.5) 11 (6.9) 62 (38.9) 28 (17.6) 
Proteus mirabilis  (136) 11 (8.0) 13 (9.5) 28 (20.5) 9 (6.6) 59 (43.7) 65 (48.1) 
Klebsiella pneumoniae (122) 20 (17.8) 21 (17.2) 35 (31.2) 9 (7.37) 54 (44.2) 52 (42.6) 
Enterococcus  (75) 64 (85.3) 59 (78.6) nt 71 (94.6) 68 (90.6) nt 
Pseudomonas aeruginosa  (50) 9 (18.0) 10 (20.0) 9 (18.0) 3 (6.0) 43 (86.0) 39 (78.0) 
Group B streptococcus  (48) 2 (4.1) 0 (0.0) nt 36 (75.0) 46 (95.8) nt 
Coagulase-negative 
staphylococci  (35) 
24 (68.5) 18 (51.4) 8 (22.8) nt 27 (77.1) nt 
Staphylococcus aureus  (29) 24 (68.5) 24 (68.5) 9 (25.7) nt 30 (85.7) 2 (6.8) 
Species   (Na)  
Penicillins Cefalosporins Carbapenem 
Ampicillin 
N   (%R) 
AMC  
N 
Cefuroxime 
N   (%R) 
Cefprozil 
N   (%R) 
Cefixime  
N   (%R) 
Ceftriaxone 
N   (%R) 
Imipenem  
N   (%R) 
Escherichia coli   (909) 680 (74.8) 
293 
(32.2) 
210 (23.1) 322 (35.5) 226 (24.9) 194 (21.3) 3 (0.3) 
Enterobacter species  (159) 138 (87.3) 69 (43.3) 67 (42.1) 88 (55.3) 65 (40.8) 60 (37.7) 3 (1.8) 
Proteus mirabilis  (136) 84 (61.7) 40 (29.4) 35 (25.7) 56 (41.1) 38 (27.9) 34 (25.0) 6 (4.4) 
Klebsiella pneumoniae (122) 119 (97.5) 45 (36.8) 42 (34.4) 53 (43.4) 34 (30.3) 38 (33.9) 1 (0.8) 
Enterococcus  (75) 10 (13.3) 8 (10.6) 72 (96.0) 73 (97.3) 72 (96.0) 74 (98.6) 5 (6.6) 
Pseudomonas aeruginosa  (50) 50 (100) 44 (88.0) 42 (84) 43 (86.0) 43 (86.0) 28 (56.0) 1 (2.0) 
Group B streptococcus  (48) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 
Coagulase-negative 
staphylococci  (35) 
35 (100) nt 24 (68.5) nt nt 18 (51.4) 10 (25.7) 
Staphylococcus aureus  (29) 29 (100) 16 (55.1) 13 (44.8) nt nt 10 (34.4) 12 (41.3) 
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The prevalence of the bacterial uropathogens 
varies from region to region and from one study 
to another study [3,5,9]. In our study, 
significant difference was also found in 
frequency of certain uropathogens in relation to 
gender. E. coli was the most predominant in 
both genders; however, its incidence was 
significantly higher in women (60.7%) than in 
men (43.4%), which was also observed in other 
similar studies [1,6,10-12]. The highest 
difference between female and male patients 
was observed for P. Mirabilis and P. 
Aeruginosa. Due to biofilm production 
capacity, P. mirabilis is a serious medical 
problem in catheter-associated UTI [1,18,19].   
Pseudomonas aeruginosa, were strongly 
associated with particular host characteristics, 
including male gender, previous history of 
using antimicrobials, prior undergoing 
interventions in the urinary and neurogenic 
bladder [19-21]. In our study, E. coli was more 
prevalent in all age groups (Pediatric, 57.7%, 
Adult 58.7%, and Elderly 57.4%).  Similar to 
previous studies that, E. coli remains the 
majority of pathogen which isolated from urine 
culture in pediatric, adult, and elderly [1, 22, 
23].  The second most common causative 
agents isolated from pediatric patients were 
Proteus mirabilis, Enterobacter species while 
adult and geriatric patients were Enterobacter 
species, K. Pneumoniae. Our finding was 
consistent with similar studies [1, 17,24]. 
Antibiotic resistance because of inappropriate 
antibiotic use has become increasingly 
encountered health problems [3,6,15]. In our 
study, resistance to antibiotics of uropathogens 
were investigated (Table-3, 4). The most 
effective antibiotics for E. coli were 
carbapenem (98.7%), amikacin (94.8%) and 
nitrofurantoin (91.0%), whereas resistance to 
ampicillin, cefprozil and trimethoprim / 
sulfamethoxazole was 74.8%, 35.5% and 
35.4%, respectively. Enterobacter species 
showed higher resistance to ampicillin (87.3%), 
lower resistance to carbapenem (1.8%) and 
Amikacin (6.9%). Our study finding is in 
agreement with other local and international 
studies [1,6,15,23].  The resistance rate of 
uropathogens Proteus mirabilis isolates to 
TMX 43.7%, to ampicillin, 61.7% to 
nitrofurantoın 48.1% to carbapenem 4.4%, 
which was similar rates shown in other studies. 
[15,19] The isolates of Klebsiella spp. showed 
a high degree of resistance to ampicillin 
(97.5%) while sensitivity rates of carbapenem 
(99.0%) and amikacin (92.7%) were observed 
similar E. coli. Our results were found to be 
consistent with the results of other studies 
[14,25]. Pseudomonas Aeruginosa was the least 
resistant to carbapenem (2.0%) and amikacin 
(6.0%) but showed a high degree of resistance 
to all other antibiotics. Previous studies also 
reported that amikacin and imipenem were the 
most effective drugs against P. Aeruginosa 
[26,27]. Enterococcus, which is the most 
commonly isolated Gram-positive bacteria, 
were resistant to cephalosporins (96.0-98.6%), 
quinolones (85.3-78.6%), amikacin (94.6%), 
TMX (90.6%), carbapenem (6.6%) and 
penicillins (13.3-10.6%). Unlike other studies, 
cephalosporin and quinolone resistance were 
found to be high, while penicillin resistance was 
lower [14,28]. Gram-positive and Gram- 
negative bacterial resistance to antibiotics is 
summarized in the table (4-5). Unlike Dordevic 
et al. [18] in Group B streptococcus, resistance 
to b-lactam antibiotics was not observed while 
95% TMX resistance and 75% amikacin 
resistance were found. The antibiotic resistance 
profiles of Staphylococcus aureus and 
Coagulase-negative staphylococci were 
consistent with other studies [14,28-30]. 
Here, we also want to specify some limitations 
of our study. As the presented data are a 
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laboratory-based on the analysis of 
microbiological samples without clinical 
background information, the rate of 
asymptomatic bacteriuria or symptomatic UTI 
could not be calculated. It includes urine 
samples taken from patients with catheters that 
may be biased to the interpretation of the 
results.  Some antibiotics have not been 
routinely tested by the microbiology laboratory; 
therefore, they were not included in our 
analysis.  Moreover, since our study is a single-
center study, there is no generalizability of the 
results to the whole society. 
As a result, as these infections are very 
common, adequate treatment has an important 
role in regard to the patients' health, 
development of antibiotic resistance and health 
care costs. This study determined the 
prevalence of urinary tract infection and 
antibiotic susceptibility patterns of the bacteria 
in outpatients. The most prevalent bacteria 
responsible for UTI were Gram- negative 
Enterobacteriaceae being that E. coli proved to 
be responsible for more than half of these 
infections. Enterococcus, which is the most 
commonly isolated Gram-positive bacteria 
responsible for UTI. These pathogens that 
cause UTIs have increased resistance to 
antibiotics in recent years. The emergence of 
bacteria resistant to various antimicrobials has 
revealed the necessity of periodic review of 
empirical antibiotic therapy at regional level. 
Therefore, the results of our retrospective study 
may help physicians to select an appropriate 
antimicrobial therapy. In conclusion, we 
suggest that antibiotic selection in the treatment 
of bacterial uropathogens should be based on 
the local prevalence and antibiotic resistance of 
bacterial organisms. 
 
Funding: There is no financial support and 
sponsorship                                               
Conflict of Interest: The authors declare that 
they have no conflict of interest. 
Informed consent: This was a retrospective 
study and all patient data were anonymized; 
informed consent was therefore not required 
under country-specific regulations. 
Ethical approval: The study was ethically 
approved by the local ethical committee of 
İstanbul Memorial Hospital (Protocol number: 
2018/7-4).                                              
 
References 
[1] Alanazi MQ, Alqahtani FY, Aleanizy FS. 
An evaluation of E. coli in urinary tract 
infection in emergency department at 
KAMC in Riyadh, Saudi Arabia: 
retrospective study. Ann Clin Microbiol 
Antimicrob. 2018; 17(3):2-7.  
[2] Yang B, Yang F, Wang S, Wang Q, Liu Z, 
Feng W, Sun F, et al. Analysis of the 
spectrum and antibiotic resistance of 
uropathogens in outpatients at a tertiary 
hospital. J Chemother. 2018;30(3):145-149.   
[3] Flores-Mireles AL, Walker JN, Caparon M, 
Hultgren SJ. Urinary tract infections: 
epidemiology, mechanisms of infection and 
treatment options. Nat Rev Microbiol. 
2015;13(5):269–84.   
[4] Foxman B. Epidemiology of urinary tract 
infections: incidence, morbidity, and 
economic costs. Am J Med. 2002;113(1):5-
13.  
[5] Stefaniuk E, Suchocka U, Bosacka K. 
Hryniewicz W. Etiology and antibiotic 
susceptibility of bacterial pathogens 
responsible for community-acquired urinary  
tract infections in Poland. Eur J Clin 
Microbiol Infect Dis. 2016;35(8):1363–69.  
[6] Magyar A, Köves B, Nagy K, Dobák A, 
Arthanareeswaran VKA, Bálint P, et al. 
Spectrum and antibiotic resistance of 
uropathogens between 2004 and 2015 in a 
                                                        Akpinar et al.  Exp Biomed Res 2019; 2(4):169-178 
   
 
177 
 
tertiary care hospital in Hungary. J Med 
Microbiol. 2017;66(6):788-97.  
[7] Yüksel S, Öztürk B, Kavaz A, Özçakar ZB, 
Acar B, Güriz H et al. Antibiotic resistance 
of urinary tract pathogens and evaluation of 
empirical treatment in Turkish children with 
urinary tract infections. Int J Antimicrob 
Agents. 2006;28:(5):413–416.  
[8] Clinical and laboratory standarts institute. 
Performance standards for antimicrobial 
testing. 7th International. CLSI Document. 
2007: M100- S16. 
[9] Lu PL, Liu YC, Toh HS, Lee YL, LiuYM, 
Ho CM et al. Epidemiology and 
antimicrobial susceptibility profiles of 
Gram-negative bacteria causing urinary tract 
infections in the Asia-Pacific region: 2009–
2010 results from the Study for Monitoring 
Antimicrobial Resistance Trends (SMART). 
Int J Antimicrob Agents. 2012;40 
(Suppl):37-43.  
[10] Bitew A, Molalign T, Chanie M. Species 
distribution and antibiotic susceptibility 
profile of bacterial uropathogens among 
patients complaining urinary tract 
infections. BMC Infect Dis. 2017;17(1):654.  
[11] Guermazi-Toumi S, Boujlel S, Assoudi M, 
Issaoui R, Tlili S, Hlaiem ME. Susceptibility 
profiles of bacteria causing urinary tract 
infections in Southern Tunisia. J Glob 
Antimicrob Resist. 2018;12:48-52. 
[12] Nzalie RNT, Gonsu H K, Koulla-Shiro S. 
Bacterial etiology and antibiotic resistance 
profile of community-acquired urinary tract 
infections in a Cameroonian city. Int J 
Microbiol. 2016;2016: 3240268.   
[13] Aykan SB, Ciftci IH. Antibiotic resistance 
patterns of Escherichia coli strains isolated 
from urine cultures in Turkey: a meta-
analysis. Mikrobiyol Bul. 2013;47(4):603- 
618.  
[14] Tandogdu Z, Cek M, Wagenlehner F, Naber 
K, Tenke P, Ostrum E, et al. Resistance 
patterns of nosocomial urinary tract 
infections in urology departments: 8-year 
results of the global prevalence of infections 
in urology study. World J Urol. 
2014;32(3):791-801.  
[15] Abuhandan M, Güzel B, Oymak Y, Çiftçi H. 
Antibiotic sensitivity and resistance in 
children with urinary tract infection in 
Sanliurfa. Turk J Urol. 2013;39(2):106-110.  
[16] Doğru A, Karatoka B, Ergen P, Aydın ÖŞ, 
Tigen ET. The resistance rates of urinary 
tract infections: Our data from year 2010. 
Turk J Urol. 2013;39(4):237-243.  
[17] Çoban B, Ülkü N, Kaplan H, Topal B, 
Erdoğan H, Baskın E. Five-year assessment 
of causative agents and antibiotic resistances 
in urinary tract infections. Turk Pediatri Ars. 
2014;49(2):124-129.  
[18] Đorđević Z, Folić M,Janković S. 
Community-acquired urinary tract 
infections: causative agents and their 
resistance to antimicrobial drugs. Vojnosanit 
Pregl. 2016;73(12):1109–1115.  
[19] Linhares I, Raposo T, Rodrigues A, Almeida 
A. Frequency and antimicrobial resistance 
patterns of bacteria implicated in community 
urinary tract infections: a ten-year 
surveillance study (2000–2009). BMC 
Infect Dis. 2013;13(19):1-14.  
[20] Tabibian JH, Gornbein J, Heidari A, Dien 
SL, Lau V H, Chahal P, et al. Uropathogens 
and host characteristics. J Clin Microbiol. 
2008;46(12), 3980-3986.  
[21] Costa T, Linhares I, Ferreira R, Neves J, 
Almeida A. Frequency and Antibiotic 
Resistance of Bacteria Implicated in 
Community Urinary Tract Infections in 
North Aveiro Between 2011 and 
2014. Microb Drug Resist. 2018;24(4):493-
504.  
                                                        Akpinar et al.  Exp Biomed Res 2019; 2(4):169-178 
   
 
178 
 
[22] Chu C.M, Lowder JL Diagnosis and 
treatment of urinary tract infections across 
age groups. Am J Obstet Gynecol. 
2018;219(1):40-51.  
[23] Erdem HA, Uysal S, Tasbakan MI, Pullukcu 
H, Sipahi OR, Yamazhan T, Ulusoy S. Is 
Urinary Tract Infection Different in Elderly 
and Adults Aged Under 65 Years? Ege 
University Experience. Mediterr J Infect 
Microb Antimicrob. 2016; 5:10. 
[24] Kahlmeter G. The ECO.SENS Project: a 
prospective, multinational, multicenter 
epidemiological survey of the prevalence 
and antimicrobial susceptibility of urinary 
tract pathogens--interim report. J 
Antimicrob Chemother. 2000;46 Suppl 
1:15-22.  
[25] Daglar D, Demirbakan H, Yıldırım Ç, 
Öztürk F, Özcan A, Sipen N et al. 
Microorganisms Isolated from Urine 
Samples and Their Antimicrobial 
Susceptibilities. Türk Mikrobiyol Cem 
Derg. 2005;35(3):189-194. 
[26] Abbas HA, El-Ganiny AM, Kamel HA. 
Phenotypic and genotypic detection of 
antibiotic resistance of Pseudomonas 
aeruginosa isolated from urinary tract 
infections. Afr Health Sci. 2018;18(1):11-
21.  
[27] Etiz P, Kibar F, Ekenoğlu Y,Yaman A. 
Evaluation of the Antibiotic Resistance 
Profiles of Enterococcus Species Isolated 
from Urine Cultures. Türk Mikrobiyol Cem 
Derg. 2014; 44(3):107-113.  
[28] Altoparlak Ü, Özbek A , Aktaş F.Antibiotic 
Susceptibilities of Gram negative Bacteria 
Isolated from Urinary Tract Infections. Turk 
Mikrobiyol Cem Derg. 2001;32(3-4): 167-
173. 
[29] Hashmi A, Abdullah FE, Abdullah NE, 
Kazmi SU. Species identification and 
antibiotic susceptibilities of coagulase-
negative staphylococci isolated from urinary 
tract infection specimens. J Coll Physicians 
Surg Pak. 2016;26(7):581-4.  
[30] Sina H, Semassa JA, TamÃ V, AdjilÃ AA, 
Baba-Moussa F, Baba-Moussa L. 
Antibiotics Resistance Profile of 
Staphylococci Isolated from Urogenital 
Infections and Toxins Production of 
Staphylococcus aureus Strains. Ann Med 
Health Sci Res. 2018;8(Suppli 1): 29-34.  
 
